$2.56T
Total marketcap
$179.9B
Total volume
BTC 49.99%     ETH 15.85%
Dominance

Harmony Biosciences HRMY Stock

31.59 USD {{ price }} -1.219510% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
1.79B USD
LOW - HIGH [24H]
31.39 - 32.45 USD
VOLUME [24H]
367.83K USD
{{ volume }}
P/E Ratio
14.83
Earnings per share
2.13 USD

Harmony Biosciences Price Chart

Harmony Biosciences HRMY Financial and Trading Overview

Harmony Biosciences stock price 31.59 USD
Previous Close 35.76 USD
Open 35.74 USD
Bid 0 USD x 800
Ask 0 USD x 1200
Day's Range 35.73 - 36.28 USD
52 Week Range 29.81 - 62.09 USD
Volume 265.93K USD
Avg. Volume 876.19K USD
Market Cap 2.17B USD
Beta (5Y Monthly) 0.446334
PE Ratio (TTM) 11.550955
EPS (TTM) 2.13 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 60.11 USD

HRMY Valuation Measures

Enterprise Value 1.99B USD
Trailing P/E 11.550955
Forward P/E 10.699115
PEG Ratio (5 yr expected) 0.49
Price/Sales (ttm) 4.6103473
Price/Book (mrq) 4.907984
Enterprise Value/Revenue 4.228
Enterprise Value/EBITDA 12.678

Trading Information

Harmony Biosciences Stock Price History

Beta (5Y Monthly) 0.446334
52-Week Change -17.53%
S&P500 52-Week Change 20.43%
52 Week High 62.09 USD
52 Week Low 29.81 USD
50-Day Moving Average 34.34 USD
200-Day Moving Average 45.45 USD

HRMY Share Statistics

Avg. Volume (3 month) 876.19K USD
Avg. Daily Volume (10-Days) 430.19K USD
Shares Outstanding 59.94M
Float 38.07M
Short Ratio 14.47
% Held by Insiders 18.87%
% Held by Institutions 90.10%
Shares Short 8.02M
Short % of Float 36.27%
Short % of Shares Outstanding 13.38%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 40.17%
Operating Margin (ttm) 28.20%
Gross Margin 81.01%
EBITDA Margin 33.35%

Management Effectiveness

Return on Assets (ttm) 14.10%
Return on Equity (ttm) 57.62%

Income Statement

Revenue (ttm) 471.67M USD
Revenue Per Share (ttm) 7.94 USD
Quarterly Revenue Growth (yoy) 39.60%
Gross Profit (ttm) 354.37M USD
EBITDA 157.3M USD
Net Income Avi to Common (ttm) 189.47M USD
Diluted EPS (ttm) 3.14
Quarterly Earnings Growth (yoy) 37.20%

Balance Sheet

Total Cash (mrq) 343.88M USD
Total Cash Per Share (mrq) 5.74 USD
Total Debt (mrq) 194.18M USD
Total Debt/Equity (mrq) 43.83 USD
Current Ratio (mrq) 4.898
Book Value Per Share (mrq) 7.39

Cash Flow Statement

Operating Cash Flow (ttm) 158.17M USD
Levered Free Cash Flow (ttm) 134.22M USD

Profile of Harmony Biosciences

Country United States
State PA
City Plymouth Meeting
Address 630 West Germantown Pike
ZIP 19462
Phone 484 539 9800
Website https://www.harmonybiosciences.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 200

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Q&A For Harmony Biosciences Stock

What is a current HRMY stock price?

Harmony Biosciences HRMY stock price today per share is 31.59 USD.

How to purchase Harmony Biosciences stock?

You can buy HRMY shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Harmony Biosciences?

The stock symbol or ticker of Harmony Biosciences is HRMY.

Which industry does the Harmony Biosciences company belong to?

The Harmony Biosciences industry is Biotechnology.

How many shares does Harmony Biosciences have in circulation?

The max supply of Harmony Biosciences shares is 56.77M.

What is Harmony Biosciences Price to Earnings Ratio (PE Ratio)?

Harmony Biosciences PE Ratio is 14.83098500 now.

What was Harmony Biosciences earnings per share over the trailing 12 months (TTM)?

Harmony Biosciences EPS is 2.13 USD over the trailing 12 months.

Which sector does the Harmony Biosciences company belong to?

The Harmony Biosciences sector is Healthcare.

Harmony Biosciences HRMY included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1454.2 USD
-0.47
1453.71 USD 1464.83 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD